Literature DB >> 24267475

American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.

Themistocles Dassopoulos1, Shahnaz Sultan, Yngve T Falck-Ytter, John M Inadomi, Stephen B Hanauer.   

Abstract

Entities:  

Keywords:  6-MP; 6-mercaptopurine; ACG; ADA; AZA; American College of Gastroenterology; BSG; British Society of Gastroenterology; CD; CDAI; CI; CZP; Crohn's Disease Activity Index; Crohn's disease; ECCO; European Crohn's and Colitis Organisation; GRADE; Grading of Recommendations Assessment, Development and Evaluation; HR; IBD; IFX; MTX; OR; PICO; RCT; RR; SIR; TNF; adalimumab; azathioprine; certolizumab pegol; confidence interval; hazard ratio; inflammatory bowel disease; infliximab; methotrexate; odds ratio; population, intervention, comparator, and outcome; randomized controlled trial; relative risk; standardized incidence ratio; tumor necrosis factor

Mesh：

Substances：

Year:  2013        PMID： 24267475     DOI： 10.1053/j.gastro.2013.10.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  36 in total

1.  Vedolizumab-Induced De Novo Extraintestinal Manifestations.

Authors:  Liege I Diaz; Tara Keihanian; Ingrid Schwartz; Su Bin Kim; Fernando Calmet; Maria Alejandra Quintero; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-02

Review 2.  Positioning therapy for Crohn's disease.

Authors:  Alexandra Gutierrez; Themistocles Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2014

3.  Are patient-reported outcome measures the way to go in inflammatory bowel disease?

Authors:  Subrata Ghosh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

4.  Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Dejan Micic; Yuga Komaki; Aleksandar Alavanja; David T Rubin; Atsushi Sakuraba
Journal:  J Clin Gastroenterol       Date:  2019-01       Impact factor: 3.062

Review 5.  Methotrexate for Inflammatory Bowel Diseases - New Developments.

Authors:  Hans H Herfarth
Journal:  Dig Dis       Date:  2016-03-16       Impact factor: 2.404

6.  Clinical Features and Prognosis of Crohn's Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients.

Authors:  Xiao-Wei Sun; Juan Wei; Zhao Yang; Xin-Xin Jin; Hai-Jun Wan; Bo-Si Yuan; Miao-Fang Yang; Jiong Liu; Fang-Yu Wang
Journal:  Dig Dis Sci       Date:  2019-05-11       Impact factor: 3.199

Review 7.  Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease.

Authors:  Ioannis Mitroulis; Vasileia I Alexaki; Ioannis Kourtzelis; Athanassios Ziogas; George Hajishengallis; Triantafyllos Chavakis
Journal:  Pharmacol Ther       Date:  2014-11-14       Impact factor: 12.310

Review 8.  Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.

Authors:  Gerassimos J Mantzaris
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

9.  Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.

Authors:  Freddy Caldera; Sumona Saha; Arnold Wald; David M Cooley; Ying-Qi Zhao; Zhanhai Li; Christie M Bartels
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-04-12       Impact factor: 3.869

10.  Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo.

Authors:  Chang Sup Lee; Kristen K Penberthy; Karen M Wheeler; Ignacio J Juncadella; Peter Vandenabeele; Jeffrey J Lysiak; Kodi S Ravichandran
Journal:  Immunity       Date:  2016-03-29       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.